A quantitative pipeline to assess secretion of human leptin coding variants reveals mechanisms underlying leptin deficiencies
Year: 2024
Type: article
Abstract: The hormone leptin, primarily secreted by adipocytes, plays a crucial role in regulating whole-body energy homeostasis. Homozygous loss-of-function mutations in the leptin gene (LEP) cause hyperphagia and severe obesity, primarily through alterations in leptin's affinity for its receptor or changes in serum leptin concentrations. Although serum concentrations are influenced by various factors (e.g., gene expression, protein synthesis, stability in the serum), proper delivery of leptin from its site of synthesis in the endoplasmic reticulum via the secretory pathway to the extracellular serum is a critical step. However, the regulatory mechanisms and specific machinery involved in this trafficking route, particularly in the context of human LEP mutations, remain largely unexplored. We have employed the Retention Using Selective Hooks system to elucidate the secretory pathway of leptin. We have refined this system into a medium-throughput assay for examining the pathophysiology of a range of obesity-associated LEP variants. Our results reveal that leptin follows the default secretory pathway, with no additional regulatory steps identified prior to secretion. Through screening of leptin variants, we identified three mutations that lead to proteasomal degradation of leptin and one variant that significantly decreased leptin secretion, likely through aberrant disulfide bond formation. These observations have identified novel pathogenic effects of leptin variants, which can be informative for therapeutics and diagnostics. Finally, our novel quantitative screening platform can be adapted for other secreted proteins.
Source: Journal of Biological Chemistry
Language: English
Subfield: Endocrine and Autonomic Systems
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,800
Funders: Wellcome Trust, National Institute for Health and Care Research, Association for Clinical Biochemistry, Novo Nordisk, Fondation Botnar, Medical Research Council, Biotechnology and Biological Sciences Research Council, Cambridge Institute for Medical Research, University of Cambridge, NIHR Cambridge Biomedical Research Centre
Awards: Molecular mechanisms of impaired glucose transport in insulin resistance, Mapping and characterising constitutive secretion in human neurons, G339059223, Spatiotemporally resolved proteomics of protein trafficking pathways, G3652455175, G4141580393, Enabling technologies, Spatiotemporally resolved proteomics of protein trafficking pathways, G5330140934, Institutional Strategic Support Fund, The University of Cambridge Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, Cambridge, Cambridge Doctoral Training Partnership - 2, Fundamental mechanisms controlling human energy homeostasis, G6432094593, G6440634711
OpenAlex ID: W4400624649
